Product Name: Human VEGF Antibody (Domantis patent anti-VEGF, Research Use)
Catalog Number: NBR-0584
Target Name: VEGF
Trade Name: Domantis patent anti-VEGF
Antibody Drug Description: The drug is a recombinant fully human anti-VEGF monoclonal antibody, being developed by Domantis. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: VEGF
Synonyms: (VEGF; VEGF-A; VPF
Target Description: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin.
Ensembl: ENSG00000112715
Uniprot: P15692